Effects of SNPs (CYP1B12 G355T, CYP1B13 C4326G, and CYP2E1*5 G-1293C), Smoking, and Drinking on Susceptibility to Laryngeal Cancer Among Han Chinese

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2014 Oct 10

PMID 25299224

Citations 5

Authors

Jianhua Jin

Faming Lin

Shiyu Liao

Qiyu Bao

Liyan Ni

Affiliations

Soon will be listed here.

Abstract

Purpose: This study was conducted to explore the effects of genetic polymorphisms (CYP1B1*2 G355T, CYP1B1*3 C4326G, and CYP2E1*5 G-1293C) and environmental factors (smoking and drinking) on susceptibility to laryngeal cancer in a Han Chinese study group.

Methods: This case-control study included 552 Han Chinese patients diagnosed with laryngeal cancer and 666 healthy control subjects of the same ethnicity, similar age, and gender. Genetic polymorphisms were examined using multi-PCR and Matrix Assisted Laser Desorption Ionization - Time of Flight (MALDI-TOF MS) methodology. The association of these genetic and environmental factors with susceptibility to laryngeal cancer was evaluated using a statistical approach.

Results: The frequencies of all three polymorphisms in the patient cohort were significantly different from those in the control cohort. Compared to the control cohort, carriers of variant alleles of CYP1B1*2 355T and CYP2E1*5 -1293C showed a higher risk for developing laryngeal cancer (for CYP1B1*2 355T, adjusted OR = 2.657, P <0.001; for CYP2E1*5 -1293C, adjusted OR = 1.938, P <0.001), while carriers of mutation allele CYP1B1*3 4326G showed a lower risk (adjusted OR = 0.562, P <0.001). Joint effects of these polymorphisms were observed. When compared to haplotype G355C4326G-1293, haplotypes T355C4326G-1293 (adjusted OR = 1.809, P <0.001), G355C4326C-1293 (adjusted OR = 1.644, P = 0.044), and T355C4326C-1293 (adjusted OR = 3.104, P <0.001) were associated with a significantly higher laryngeal cancer risk. The adjusted ORs for non-smokers, non-drinkers, smokers, and drinkers with the GT/TT genotype at CYP1B1*2 G355T were 2.190 (P = 0.006), 2.008 (P = 0.001), 5.875 (P <0.001), and 4.518 (P <0.001), respectively.

Conclusions: CYP1B1*2 355T and CYP2E1*5 -1293C are associated with an increased laryngeal cancer risk, while CYP1B1*3 4326G is associated with a decreased risk. These polymorphisms showed joint effects on laryngeal cancer risk. Smoking and drinking showed collaborative effects with two high risk alleles (CYP1B1*2 355T and CYP1B1*3 4326G) for promoting laryngeal cancer risk.

Citing Articles

The Influence of Cytochrome P450 Polymorphisms on Pharmacokinetic Profiles and Treatment Outcomes Among Malaria Patients in Sub-Saharan Africa: A Systematic Review.

J Marwa K, Kapesa A, Kamugisha E, Swedberg G Pharmgenomics Pers Med. 2023; 16:449-461.

PMID: 37223718 PMC: 10202199. DOI: 10.2147/PGPM.S379945.

Role of Genetic Polymorphisms in Drug-Metabolizing Enzyme-Mediated Toxicity and Pharmacokinetic Resistance to Anti-Cancer Agents: A Review on the Pharmacogenomics Aspect.

Narendra G, Choudhary S, Raju B, Verma H, Silakari O Clin Pharmacokinet. 2022; 61(11):1495-1517.

PMID: 36180817 DOI: 10.1007/s40262-022-01174-7.

Ornithine decarboxylase (ODC1) gene variant (rs2302615) is associated with gastric cancer independently of Helicobacter pylori CagA serostatus.

Miller A, Tavera G, Dominguez R, Camargo M, Waterboer T, Wilson K Oncogene. 2021; 40(40):5963-5969.

PMID: 34376808 PMC: 8692072. DOI: 10.1038/s41388-021-01981-5.

Does CYP2E1 RsaI/PstI polymorphism confer head and neck carcinoma susceptibility?: A meta-analysis based on 43 studies.

Zhuo X, Song J, Liao J, Zhou W, Ye H, Li Q Medicine (Baltimore). 2016; 95(43):e5156.

PMID: 27787372 PMC: 5089101. DOI: 10.1097/MD.0000000000005156.

Association between UGT1A1 Polymorphism and Risk of Laryngeal Squamous Cell Carcinoma.

Huangfu H, Pan H, Wang B, Wen S, Han R, Li L Int J Environ Res Public Health. 2016; 13(1).

PMID: 26751466 PMC: 4730503. DOI: 10.3390/ijerph13010112.

References

Shimada T, Watanabe J, Inoue K, Guengerich F, Gillam E . Specificity of 17beta-oestradiol and benzo[a]pyrene oxidation by polymorphic human cytochrome P4501B1 variants substituted at residues 48, 119 and 432. Xenobiotica. 2001; 31(3):163-76. DOI: 10.1080/00498250110043490. View

Lu D, Yu X, Du Y . Meta-analyses of the effect of cytochrome P450 2E1 gene polymorphism on the risk of head and neck cancer. Mol Biol Rep. 2010; 38(4):2409-16. DOI: 10.1007/s11033-010-0375-9. View

Tai J, Yang M, Ni X, Yu D, Fang J, Tan W . Genetic polymorphisms in cytochrome P450 genes are associated with an increased risk of squamous cell carcinoma of the larynx and hypopharynx in a Chinese population. Cancer Genet Cytogenet. 2009; 196(1):76-82. DOI: 10.1016/j.cancergencyto.2009.08.015. View

Shah P, Singh A, Singh M, Mathur N, Mishra B, Pant M . Association of functionally important polymorphisms in cytochrome P4501B1 with lung cancer. Mutat Res. 2008; 643(1-2):4-10. DOI: 10.1016/j.mrfmmm.2008.05.001. View

Zhang H, Li L, Xu Y . CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis. PLoS One. 2013; 8(7):e68634. PMC: 3701676. DOI: 10.1371/journal.pone.0068634. View

Sissung T, Price D, Sparreboom A, Figg W . Pharmacogenetics and regulation of human cytochrome P450 1B1: implications in hormone-mediated tumor metabolism and a novel target for therapeutic intervention. Mol Cancer Res. 2006; 4(3):135-50. DOI: 10.1158/1541-7786.MCR-05-0101. View

Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin. 2011; 61(2):69-90. DOI: 10.3322/caac.20107. View

Ruwali M, Khan A, Shah P, Singh A, Pant M, Parmar D . Cytochrome P450 2E1 and head and neck cancer: interaction with genetic and environmental risk factors. Environ Mol Mutagen. 2009; 50(6):473-82. DOI: 10.1002/em.20488. View

Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, Curado M . Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst. 2007; 99(10):777-89. DOI: 10.1093/jnci/djk179. View

10.

Ko Y, Abel J, Harth V, BRODE P, Antony C, Donat S . Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue. Cancer Res. 2001; 61(11):4398-404. View

11.

Jaworowska E, Masojc B, Tarnowska C, Brzosko M, Flicinski J, Serrano-Fernandez P . Association between early-onset breast and laryngeal cancers. Breast Cancer Res Treat. 2005; 97(2):215-9. DOI: 10.1007/s10549-005-9116-5. View

12.

Gajecka M, Rydzanicz M, Jaskula-Sztul R, Kujawski M, Szyfter W, Szyfter K . CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma. Mutat Res. 2005; 574(1-2):112-23. DOI: 10.1016/j.mrfmmm.2005.01.027. View

13.

Tang K, Li Y, Zhang Z, Gu Y, Xiong Y, Feng G . The PstI/RsaI and DraI polymorphisms of CYP2E1 and head and neck cancer risk: a meta-analysis based on 21 case-control studies. BMC Cancer. 2010; 10:575. PMC: 2988025. DOI: 10.1186/1471-2407-10-575. View

14.

Trubicka J, Grabowska-Klujszo E, Suchy J, Masojc B, Serrano-Fernandez P, Kurzawski G . Variant alleles of the CYP1B1 gene are associated with colorectal cancer susceptibility. BMC Cancer. 2010; 10:420. PMC: 2929240. DOI: 10.1186/1471-2407-10-420. View

15.

Singh A, Shah P, Mathur N, Buters J, Pant M, Parmar D . Genetic polymorphisms in cytochrome P4501B1 and susceptibility to head and neck cancer. Mutat Res. 2007; 639(1-2):11-9. DOI: 10.1016/j.mrfmmm.2007.10.007. View

16.

Guengerich F, Kim D, Iwasaki M . Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol. 1991; 4(2):168-79. DOI: 10.1021/tx00020a008. View

17.

Roos P, Bolt H . Cytochrome P450 interactions in human cancers: new aspects considering CYP1B1. Expert Opin Drug Metab Toxicol. 2006; 1(2):187-202. DOI: 10.1517/17425255.1.2.187. View

18.

Ickstadt K, Schafer M, Fritsch A, Schwender H, Abel J, Bolt H . Statistical methods for detecting genetic interactions: a head and neck squamous-cell cancer study. J Toxicol Environ Health A. 2008; 71(11-12):803-15. DOI: 10.1080/15287390801985745. View

19.

Ohshima H, Tazawa H, Sylla B, Sawa T . Prevention of human cancer by modulation of chronic inflammatory processes. Mutat Res. 2005; 591(1-2):110-22. DOI: 10.1016/j.mrfmmm.2005.03.030. View

20.

Helmig S, Seelinger J, Philipp-Gehlhaar M, Dohrel J, Schneider J . Cyp1B1 mRNA expression in correlation to cotinine levels with respect to the Cyp1B1 L432V gene polymorphism. Eur J Epidemiol. 2010; 25(12):867-73. DOI: 10.1007/s10654-010-9505-x. View

Effects of SNPs (CYP1B1*2 G355T, CYP1B1*3 C4326G, and CYP2E1*5 G-1293C), Smoking, and Drinking on Susceptibility to Laryngeal Cancer Among Han Chinese

Effects of SNPs (CYP1B12 G355T, CYP1B13 C4326G, and CYP2E1*5 G-1293C), Smoking, and Drinking on Susceptibility to Laryngeal Cancer Among Han Chinese